Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2025, Vol. 30 ›› Issue (11): 1569-1577.doi: 10.12092/j.issn.1009-2501.2025.11.015

Previous Articles     Next Articles

Research progress of targeted nanoparticles in the treatment of cervical cancer

HAN Xue1, WANG Dan2, LIU Huiling1   

  1. 1Department of Gynecology, Gansu Provincial People's Hospital, Lanzhou 730000, Gansu, China; 2Department of Gynecology, The 940th Hospital, Joint Logistics Support Force of PLA, Lanzhou 730050, Gansu, China
  • Received:2024-10-09 Revised:2025-01-09 Online:2025-11-26 Published:2025-12-04

Abstract:

Cervical cancer is one of the most common gynecological malignancies, which seriously threatens women's life and health. Traditional treatment methods are still mainly surgery and chemotherapy, these methods have improved the overall prognosis of cervical cancer patients, there are still many problems such as tumor recurrence and drug resistance. In recent years, with the development of nanotechnology, targeted nanoparticles can not only improve the solubility, stability and biodistribution of drugs, but also achieve minimally invasive drug release. It is a new type of drug targeted delivery system with great therapeutic potential. This article summarizes the latest research progress of nano-targeted drug delivery systems in the field of cervical cancer treatment, and looks forward to the challenges and development directions in this field.

Key words: cervical cancer, nanoparticles, drug delivery systems, lipid nanocarriers, polymer nanoparticles

CLC Number: